Recent News

• 03.26.2026 - Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• 03.26.2026 - Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• 01.29.2026 - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
• 01.29.2026 - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
• 01.27.2026 - Vivani Medical, Inc. Announces Closing of Common Stock Offering
• 01.27.2026 - Vivani Medical, Inc. Announces Closing of Common Stock Offering
• 01.26.2026 - Vivani Medical, Inc. Announces Pricing of Common Stock Offering
• 01.26.2026 - Vivani Medical, Inc. Announces Pricing of Common Stock Offering
• 01.22.2026 - Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
• 01.22.2026 - Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026

Recent Filings

• 03.26.2026 - EX-99.1 EX-99.1
• 03.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.26.2026 - 8-K Current report
• 03.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2026 - EX-99.1 EX-99.1
• 01.27.2026 - 8-K Current report
• 01.27.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.20.2026 - 4 Statement of changes in beneficial ownership of securities